Figure 1 | Scientific Reports

Figure 1

From: Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

Figure 1

(A) Study design and (B) Disposition of patients. *Activated vitamin D drugs and their derivatives (calcitriol, maxacalcitol, falecalcitriol, alfacalcidol, and eldecalcitol), phosphate binders and calcium preparations (precipitated calcium carbonate, sevelamer hydrochloride, lanthanum carbonate, bixalomer, aluminum preparations, niceritrol, colestimide, colestyramine, ferric citrate hydrate, and others), and food with phosphorus binding effects (e.g. calcium acetate, eggshell calcium).

Back to article page